Esta es un versión antigua publicada el 2019-05-31. Consulte la versión más reciente.
Inhibición de Enterobacter cloacae por Bifidobacterium longum
DOI:
https://doi.org/10.33064/iycuaa2019772094Palabras clave:
Bifidobacterium longum, Enterobacter cloacae, probióticos, postbióticos, microbiota, interferencia microbianaResumen
Enterobacter cloacae forma parte de la microbiota intestinal en humanos, pertenece al phylum de las Proteobacterias, familia Enterobacteriaceae, género Enterobacter, especie E. cloacae; se caracteriza por ser ubicua, oportunista, fármaco-resistente y responsable de bacteriemias e infecciones nosocomiales, por lo que se hace necesaria la búsqueda de alternativas para su tratamiento y control. En este trabajo se muestra evidencia de la inhibición del crecimiento de E. cloacae empleando metabolitos bacterianos o sobrenadantes libres de células (también conocidos como postbióticos) producidos por Bifidobacterium longum (probiótico que pertenece al filo Actinobacteria); varios trabajos demuestran la importancia de estos para inhibir el crecimiento de diversos microorganismos patógenos. En este trabajo se evaluó el liofilizado de los postbióticos de B. longum, observándose un 99% de inhibición de E. cloacae en cultivos in vitro. Estos resultados se suman a las diversas investigaciones con probióticos encaminados al tratamiento y prevención de infecciones ocasionadas por E. cloacae.
Descargas
Los datos de descargas todavía no están disponibles.
Métricas
Cargando métricas ...
Citas
• Aguilar-Toalá, J. E., García-Varela, R., García, H. S., Mata-Haro, V., González-Córdova, A. F., Vallejo-Córdoba, B., & Hernández-Mendoza, A. (2018). Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology, 75, 105-114. doi: 10.1016/j.tifs.2018.03.009
• Barrón González, M. P., Serrano Vázquez, G. C., Villarreal Treviño, L., Verduzco Martínez, J. A., Morales Vallarta, M. R., & Mata Cárdenas, B. D. (2008). Inhibición del crecimiento axénico in vitro de Entamoeba histolytica por acción de probióticos. Ciencia-UANL, 11, 235-290.
• Bernet, M. F., Brassart, D., Neeser, J. R., & Servin, A. L. (1993). Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Applied and Environmental Microbiology, 59(12), 4121-4128.
• Chmielewska, A., & Szajewska, H. (2010). Systematic review of randomised controlled trials: Probiotics for functional constipation. World Journal of Gastroenterology, 16(1), 69-75. doi: 10.3748/wjg.v16.i1.69
• Cicenia, A., Santangelo, F., Gambardella, L., Pallotta, L., Iebba, V., Scirocco, A.,… Severi, C. (2016). Protective role of postbiotic mediators secreted by Lactobacillus rhamnosus GG versus Lipopolysaccharide-induced damage in human colonic smooth muscle cells. Journal of Clinical Gastroenterology, 50, S140-S144. doi: 10.1097/MCG.0000000000000681
• De-Martinis, E. C. P., Alves, V. F., & Franco, B. D. G. M. (2002). Fundamentals and perspectives for the use of bacteriocins produce by lactic acid bacteria in the meat products. Food Reviews International, 18(2-3), 191-208. doi: 10.1081/FRI-120014688
• Demers, M., Dagnault, A., & Desjardins, J. (2014). A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clinical Nutrition, 33(5), 761-767. doi: 10.1016/j.clnu.2013.10.015
• Di Gioia, D., Aloisio, I., Mazzola, G., & Biavati, B. (2014). Bifidobacteria: Their impact on gut microbiota composition and their applications as probiotics in infants. Applied Microbiology and Biotechnology, 98(2), 563-577. doi: 10.1007/s00253-013-5405-9
• Donohue, D. C., & Salminen, S. (1996). Safety of probiotic bacteria. Asia Pacific Journal of Clinical Nutrition, 5(1), 25-28.
• Dylag, K., Hubalewska-Mazgaj, M., Surmiak, M., Szmyd, J., & Brzozowski, T. (2014). Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Current Pharmaceutical Design, 20(7), 1149-1155. doi: 10.2174/13816128113199990422
• Falagas, M. E., Rafailidis, P., & Makris, G. C. (2008). Bacterial interference for the prevention and treatment of infections. International Journal of Antimicrobial Agents, 31(6), 518-522. doi: 10.1016/j.ijantimicag.2008.01.024
• Fijan, S. (2014). Microorganisms with claimed probiotic properties: An overview of recent literature. International Journal of Environmental Research and Public Health, 11(5), 4745-4767. doi: 10.3390/ijerph110504745
• Food and Agriculture Organization of the United Nations World Health Organization. (2002). Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO Working Group on drafting guidelines for hte evaluation of probiotics in food. London Ontario, Canada, April 30 and May 1, 2002. Recuperado el 10 de marzo de 2018, de http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
• Fuller, R., & Gibson, G. R. (1997). Modification of the intestinal microflora using probiotics and prebiotics. Scandinavian Journal of Gastroenterology, 32(222), 28-31. doi: 10.1080/00365521.1997.11720714
• González-Martínez, B. E., Gómez-Treviño, M., & Jiménez-Salas, Z. (2003). Bacteriocinas de probióticos. Revista de Salud Pública y Nutrición, 4(2). Recuperado de http://www.medigraphic.com/pdfs/revsalpubnut/spn-2003/spn032g.pdf
• Harmsen, H. J., Wildeboer-Veloo, A. C. M., Raangs, G. C., Wagendorp, A. A., Klijn, N., Bindels J. G., & Welling, G. W. (2000). Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition, 30(1), 61-67. Recuperado de https://journals.lww.com/jpgn/Fulltext/2000/01000/Analysis_of_Intestinal_Flora_Development_in.19.aspx
• Hempel, S., Newberry, S. J., Maher, A. R., Wang, Z., Miles, J. N. V., Shanman, R.,…, Shekelle, P. G. (2012). Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. Journal of the American Medical Association, 307(18), 1959-1969. doi: 10.1001/jama.2012.3507
• Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., …, Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews. Gastroenterology & Hepatology, 11, 506-514. doi: 10.1038/nrgastro.2014.66
• Íñiguez-Palomares, C., & Acedo-Félix, E. (2006). Mecanismos de adhesión al tracto intestinal y anatagonismo de Bifidobacterium. Revista de Salud Pública y Nutrición, 7(2). Recuperado de http://respyn.uanl.mx/index.php/respyn/article/view/168
• Isolauri, E., Rautava, S., & Salminen, S. (2012). Probiotics in the development and treatment of allergic disease. Gastroenterology Clinics of North America, 41(4), 747-762. doi: 10.1016/j.gtc.2012.08.007
• Livermore, D. M. (1998). β-lactamase-mediated resistance and opportunities for its control. Journal of Antimicrobial Chemotherapy, 41(4), 25-41. doi: 10.1093/jac/41.suppl_4.25
• McFarland, L. V. (2007). Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease, 5(2), 97-105. doi: 10.1016/j.tmaid.2005.10.003
• Mezzatesta, M. L., Gona, F., & Stefani, S. (2012). Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance. Future Microbiology, 7(7), 887-902. doi: 10.2217/fmb.12.61
• Moon, G. S., Pyun, Y. R., Park, M. S., Ji, G. E., & Kim, W. J. (2005). Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for Bifidobacterial α-amylase. Applied and Environmental Microbiology, 71(9), 5630-5632. doi: 10.1128/AEM.71.9.5630-5632.2005
• Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (Eds.). (2006). Microbiología médica (5ª. ed., pp. 323-335). España: Elsevier.
• Musil, I., Jensen, V., Schilling, J., Ashdown, B., & Kent, T. (2010). Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: A case report. Journal of Medical Case Reports, 4,131. doi: 10.1186/1752-1947-4-131
• Norma Mexicana NMX-F-608-NORMEX-2011. Alimentosdeterminación de proteínas en alimentos/método de ensayoprueba. Recuperado el 14 marzo de 2018, de dof.gob.mx/nota_detalle.php?codigo=4858024&fecha=04/08/0980
• Pérez, P. F., Minnaard, J., Rouvet, M., Knabenhans, C., Brassart, D., De Antoni, G. L., & Schiffrin, E. J. (2001). Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: An in vitro Study. Applied and Environmental Microbiology, 67(11), 5037-5042. doi: 10.1128/AEM.67.11.5037-5042.2001
• Ruiz, L., Margolles, A., & Sánchez, B. (2013). Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Frontiers in Microbiology, 4, 396. doi: 10.3389/fmicb.2013.00396
• Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M. M., Sartor, R. B. …, Mayer, E. A. (2013). An update on the use and investigation of probiotics in health and disease. Gut, 62(5), 787-796. doi: 10.1136/gutjnl-2012-302504
• Schell, M. (s. f.). Bifidobacterium longum [Fotografía]. Athens, GA: University of Georgia.
• Secretaría de Salud. (26 de junio de 1996). Norma Oficial Mexicana NOM-086-SSA1-1994, Bienes y Servicios. Alimentos y bebidas no alcohólicas con modificaciones en su composición. Especificaciones nutrimentales. Diario Oficial de la Federación. Recuperado el 14 de marzo de 2018, de dof.gob.mx/nota_detalle.php?cdigo=5172062&fecha=22/12/2010
• Tsilingiri, K., & Rescigno, M. (2013). Postbiotics: What else? Beneficial Microbes, 4(1), 101-107. doi: 10.3920/BM2012.0046
• World Health Organization. (2017). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Recuperado el 10 de marzo de 2018, de http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
• Barrón González, M. P., Serrano Vázquez, G. C., Villarreal Treviño, L., Verduzco Martínez, J. A., Morales Vallarta, M. R., & Mata Cárdenas, B. D. (2008). Inhibición del crecimiento axénico in vitro de Entamoeba histolytica por acción de probióticos. Ciencia-UANL, 11, 235-290.
• Bernet, M. F., Brassart, D., Neeser, J. R., & Servin, A. L. (1993). Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Applied and Environmental Microbiology, 59(12), 4121-4128.
• Chmielewska, A., & Szajewska, H. (2010). Systematic review of randomised controlled trials: Probiotics for functional constipation. World Journal of Gastroenterology, 16(1), 69-75. doi: 10.3748/wjg.v16.i1.69
• Cicenia, A., Santangelo, F., Gambardella, L., Pallotta, L., Iebba, V., Scirocco, A.,… Severi, C. (2016). Protective role of postbiotic mediators secreted by Lactobacillus rhamnosus GG versus Lipopolysaccharide-induced damage in human colonic smooth muscle cells. Journal of Clinical Gastroenterology, 50, S140-S144. doi: 10.1097/MCG.0000000000000681
• De-Martinis, E. C. P., Alves, V. F., & Franco, B. D. G. M. (2002). Fundamentals and perspectives for the use of bacteriocins produce by lactic acid bacteria in the meat products. Food Reviews International, 18(2-3), 191-208. doi: 10.1081/FRI-120014688
• Demers, M., Dagnault, A., & Desjardins, J. (2014). A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clinical Nutrition, 33(5), 761-767. doi: 10.1016/j.clnu.2013.10.015
• Di Gioia, D., Aloisio, I., Mazzola, G., & Biavati, B. (2014). Bifidobacteria: Their impact on gut microbiota composition and their applications as probiotics in infants. Applied Microbiology and Biotechnology, 98(2), 563-577. doi: 10.1007/s00253-013-5405-9
• Donohue, D. C., & Salminen, S. (1996). Safety of probiotic bacteria. Asia Pacific Journal of Clinical Nutrition, 5(1), 25-28.
• Dylag, K., Hubalewska-Mazgaj, M., Surmiak, M., Szmyd, J., & Brzozowski, T. (2014). Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Current Pharmaceutical Design, 20(7), 1149-1155. doi: 10.2174/13816128113199990422
• Falagas, M. E., Rafailidis, P., & Makris, G. C. (2008). Bacterial interference for the prevention and treatment of infections. International Journal of Antimicrobial Agents, 31(6), 518-522. doi: 10.1016/j.ijantimicag.2008.01.024
• Fijan, S. (2014). Microorganisms with claimed probiotic properties: An overview of recent literature. International Journal of Environmental Research and Public Health, 11(5), 4745-4767. doi: 10.3390/ijerph110504745
• Food and Agriculture Organization of the United Nations World Health Organization. (2002). Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO Working Group on drafting guidelines for hte evaluation of probiotics in food. London Ontario, Canada, April 30 and May 1, 2002. Recuperado el 10 de marzo de 2018, de http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
• Fuller, R., & Gibson, G. R. (1997). Modification of the intestinal microflora using probiotics and prebiotics. Scandinavian Journal of Gastroenterology, 32(222), 28-31. doi: 10.1080/00365521.1997.11720714
• González-Martínez, B. E., Gómez-Treviño, M., & Jiménez-Salas, Z. (2003). Bacteriocinas de probióticos. Revista de Salud Pública y Nutrición, 4(2). Recuperado de http://www.medigraphic.com/pdfs/revsalpubnut/spn-2003/spn032g.pdf
• Harmsen, H. J., Wildeboer-Veloo, A. C. M., Raangs, G. C., Wagendorp, A. A., Klijn, N., Bindels J. G., & Welling, G. W. (2000). Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition, 30(1), 61-67. Recuperado de https://journals.lww.com/jpgn/Fulltext/2000/01000/Analysis_of_Intestinal_Flora_Development_in.19.aspx
• Hempel, S., Newberry, S. J., Maher, A. R., Wang, Z., Miles, J. N. V., Shanman, R.,…, Shekelle, P. G. (2012). Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. Journal of the American Medical Association, 307(18), 1959-1969. doi: 10.1001/jama.2012.3507
• Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., …, Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews. Gastroenterology & Hepatology, 11, 506-514. doi: 10.1038/nrgastro.2014.66
• Íñiguez-Palomares, C., & Acedo-Félix, E. (2006). Mecanismos de adhesión al tracto intestinal y anatagonismo de Bifidobacterium. Revista de Salud Pública y Nutrición, 7(2). Recuperado de http://respyn.uanl.mx/index.php/respyn/article/view/168
• Isolauri, E., Rautava, S., & Salminen, S. (2012). Probiotics in the development and treatment of allergic disease. Gastroenterology Clinics of North America, 41(4), 747-762. doi: 10.1016/j.gtc.2012.08.007
• Livermore, D. M. (1998). β-lactamase-mediated resistance and opportunities for its control. Journal of Antimicrobial Chemotherapy, 41(4), 25-41. doi: 10.1093/jac/41.suppl_4.25
• McFarland, L. V. (2007). Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Medicine and Infectious Disease, 5(2), 97-105. doi: 10.1016/j.tmaid.2005.10.003
• Mezzatesta, M. L., Gona, F., & Stefani, S. (2012). Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance. Future Microbiology, 7(7), 887-902. doi: 10.2217/fmb.12.61
• Moon, G. S., Pyun, Y. R., Park, M. S., Ji, G. E., & Kim, W. J. (2005). Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for Bifidobacterial α-amylase. Applied and Environmental Microbiology, 71(9), 5630-5632. doi: 10.1128/AEM.71.9.5630-5632.2005
• Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (Eds.). (2006). Microbiología médica (5ª. ed., pp. 323-335). España: Elsevier.
• Musil, I., Jensen, V., Schilling, J., Ashdown, B., & Kent, T. (2010). Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: A case report. Journal of Medical Case Reports, 4,131. doi: 10.1186/1752-1947-4-131
• Norma Mexicana NMX-F-608-NORMEX-2011. Alimentosdeterminación de proteínas en alimentos/método de ensayoprueba. Recuperado el 14 marzo de 2018, de dof.gob.mx/nota_detalle.php?codigo=4858024&fecha=04/08/0980
• Pérez, P. F., Minnaard, J., Rouvet, M., Knabenhans, C., Brassart, D., De Antoni, G. L., & Schiffrin, E. J. (2001). Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: An in vitro Study. Applied and Environmental Microbiology, 67(11), 5037-5042. doi: 10.1128/AEM.67.11.5037-5042.2001
• Ruiz, L., Margolles, A., & Sánchez, B. (2013). Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Frontiers in Microbiology, 4, 396. doi: 10.3389/fmicb.2013.00396
• Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M. M., Sartor, R. B. …, Mayer, E. A. (2013). An update on the use and investigation of probiotics in health and disease. Gut, 62(5), 787-796. doi: 10.1136/gutjnl-2012-302504
• Schell, M. (s. f.). Bifidobacterium longum [Fotografía]. Athens, GA: University of Georgia.
• Secretaría de Salud. (26 de junio de 1996). Norma Oficial Mexicana NOM-086-SSA1-1994, Bienes y Servicios. Alimentos y bebidas no alcohólicas con modificaciones en su composición. Especificaciones nutrimentales. Diario Oficial de la Federación. Recuperado el 14 de marzo de 2018, de dof.gob.mx/nota_detalle.php?cdigo=5172062&fecha=22/12/2010
• Tsilingiri, K., & Rescigno, M. (2013). Postbiotics: What else? Beneficial Microbes, 4(1), 101-107. doi: 10.3920/BM2012.0046
• World Health Organization. (2017). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Recuperado el 10 de marzo de 2018, de http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
Descargas
Publicado
2019-05-31
Versiones
- 2019-05-31 (2)
- 2019-05-31 (1)
Cómo citar
Barrón-González, M. P., Mireles-Rangel, C., Cuéllar-Guevara, F. L., Eguiarte-Lara, D. J., & Quiñones-Gutiérrez, Y. (2019). Inhibición de Enterobacter cloacae por Bifidobacterium longum. Investigación Y Ciencia De La Universidad Autónoma De Aguascalientes, (77), 19–26. https://doi.org/10.33064/iycuaa2019772094
Licencia
Las obras publicadas en versión electrónica de la revista están bajo la licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
